Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Dendreon Corporation    DNDNQ   US24823Q1076

DENDREON CORPORATION (DNDNQ)

24
Delayed Quote. Delayed Nasdaq - 03/04 03:59:43 pm
0.0558 USD   -0.36%
02/20DJValeant Approved to Buy Dendreon Assets for $495 Million
02/20 Drugmaker Valeant close to buying Salix - source
02/12 VALEANT SECURES : Bloomberg
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/26/2015 02/27/2015 03/02/2015 03/03/2015 03/04/2015 Date
0.0578(c) 0.056(c) 0.058(c) 0.056(c) 0.0558(c) Last
1 368 490 1 344 856 1 126 662 1 662 094 1 863 670 Volume
-6.02% -3.11% +3.57% -3.45% -0.36% Change
More quotes
Company
Dendreon Corp. is a biotechnology company, which focuses on discovery, development and commercialization of novel therapeutics that improves cancer treatment options for patients.The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular... 
More about the company
Surperformance© ratings of Dendreon Corporation
Trading Rating : Investor Rating :
More Ratings
Chart DENDREON CORPORATION
Duration : Period :
Dendreon Corporation Technical Analysis Chart | DNDNQ | US24823Q1076 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 299 M
EBIT 2014 -57,0 M
Net income 2014 -107 M
Debt 2014 -
Yield 2014 -
Sales 2015 317 M
EBIT 2015 -56,8 M
Net income 2015 -73,1 M
Debt 2015 421 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 0,03x
EV / Sales 2015 1,35x
Capitalization 8,89 M
More Financials
Latest news on DENDREON CORPORATION
02/27 DENDREON : Change in Directors or Principal Officers, Other Events, Financial St..
02/23 DENDREON : Completion of Acquisition or Disposition of Assets, Change in Directo..
02/20DJValeant Approved to Buy Dendreon Assets for $495 Million
02/20 Drugmaker Valeant close to buying Salix - source
02/20 DENDREON : Entry into a Material Definitive Agreement, Financial Statements and ..
02/20 VALEANT PHARMACEUTICALS INTL : Announces Expiration Of Bid Deadline In Connectio..
02/19 DENDREON : Announces Expiration of Bid Deadline in Connection with Agreement to ..
02/19 DENDREON : Regulation FD Disclosure (form 8-K)
More news
Sector news Biotechnology & Medical Research - NEC
06:27p JOHNSON & JOHNSON : Report: J&J close to deal to buy partner Pharmacyclics
04:39pDJJohnson &Johnson Near Deal for Drugmaker Pharmacyclics -FT
03/03 ALKERMES : rsquo; Corporate Presentation to be Webcast at the Barclays Global He..
Plus d'actualités du secteur Biotechnology & Medical Research - NEC
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF